Review will encompass quantitative formulation of price stability, monetary policy toolkit, economic and monetary analyses and communication practices Other considerations, such as financial stability, employment and environmental sustainability, will also be part of review Expected to be concluded by end of 2020 Review will be based on thorough analysis and open minds, engaging with all […]
The first confirmed cases of 2019-nCoV in Europe are not unexpected. Their identification proves that detection and confirmation of this novel virus is working in France, showing a high level of preparedness to prevent and control further infections.
The Constitutional Affairs Committee agreed on Thursday to recommend that the EP plenary should approve the UK withdrawal terms.
First EU climate bank agreement with a large EU city EIB Vice-President McDowell: signal for other cities in Europe City Councillor Peter Hanke: Vienna as a “climate model city” pioneer in Europe
308,000 counterfeit euro banknotes were withdrawn from circulation in the second half of 2019 Over 70% of those counterfeits were €20 and €50 banknotes Euro banknotes continue to be a trusted and safe means of payment All euro banknotes can be verified using the “feel, look and tilt” method
Such an agreement may be regarded as a restriction of competition by object or by effect and as an abuse of a dominant position.
In the week ending 17 January 2020 the net position of the Eurosystem in foreign currency (asset items 2 and 3 minus liability items 7, 8 and 9) increased by EUR 1.4 billion to EUR 291.9 billion.
The Directive on privacy and electronic communications is applicable, in principle, when the providers of electronic communication services are obliged by law to retain the data of their subscribers and to allow the public authorities access to that data, irrespective of whether those obligations are imposed on national security grounds.
EMA suspends Picato as a precaution while review of skin cancer risk continues.
The joint Big Data Task Force of EMA and the Heads of Medicines Agencies (HMA) proposes ten priority actions for the European medicines regulatory network to evolve its approach to data use and evidence generation, in order to make best use of big data to support innovation and public health, in a report published today.
